The Valley Desk

Clinical trial reportThe Journal of clinical psychiatryPublished

Esketamine Nasal Spray vs Quetiapine Extended-Release: Examining Work Productivity Loss and Related Costs in Patients With Treatment-Resistant Depression

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
The Journal of clinical psychiatry
Published
Subject terms
Humans; Ketamine; Antipsychotic Agents; Antidepressive Agents; Delayed-Action Preparations; Drug Therapy, Combination; Efficiency; Adult; Middle Aged; Female; Male; Nasal Sprays
PubMed ID
39898892
Added to directory
Source checked

Report a correction or request removal